IP Library Granted Patent US 10,328,395
Granted Patent B2
US 10,328,395 · App. 15/714,648 · Granted Jun 25, 2019

Systems, devices, and methods for bodily fluid separation materials

Inventors: Samartha Anekal (San Jose, CA); Deborah Sloan (San Ramon, CA)
Assignee: Theranos IP Company, LLC
B01D69/12A61M1/34A61M1/3403B01D65/02B01D67/0088B01D69/06B01D71/68A61M2202/0415A61M2207/00B01D2325/14B01D2325/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,328,395
App. No.
15/714,648
Granted
Jun 25, 2019
Kind
B2
Abstract

In one embodiment described herein, a bodily fluid separation material is provided comprising a formed component capture region and a bodily fluid pass-through region. The pass-through region has structures with a reduced liquid leaching quality relative to than the capture region, wherein during separation material use, bodily fluid enters the capture region prior to entering the pass-through region. Optionally, a bodily fluid pass-through region has a reduced amount of liquid leaching material relative to than the capture region.

Claims (27)

1. A bodily fluid separation material comprising:

a first capture region formed of a first material and having an anti-hemolytic surface coating not comprising the first material;

a second capture region formed of the first material and without the anti-hemolytic surface coating not comprising the first material; and

a bodily fluid pass-through region formed of the first material and comprising pass-through openings sized so that formed components of the bodily fluid do not enter the bodily fluid pass-through region.

2. The separation material of claim 1 wherein at least a portion of the separation material comprises an asymmetric polyethersulfone.

3. The separation material of claim 1 wherein at least a portion of the separation material comprises polyarylethersulfone.

4. The separation material of claim 1 wherein at least a portion of the separation material comprises an asymmetric polyarylethersulfone.

5. The separation material of claim 1 wherein at least a portion of the separation material comprises a polysulfone.

6. The separation material of claim 1 wherein the separation material comprises an asymmetric polysulfone.

7. The separation material of claim 1 wherein the anti-hemolytic surface coating comprises single and/or double alkyl chain N-oxides of tertiary amines (NTA).

8. The separation material of claim 1 having a flat, planar shape.

9. The separation material of claim 1 wherein at least a portion of the separation material comprises a polyethersulfone.

10. A bodily fluid separation material comprising:

a first capture region formed of a first material and having an anti-hemolytic surface coating not comprising the first material;

a second capture region formed of the first material and without the anti-hemolytic surface coating not comprising the first material; and

a bodily fluid pass-through region formed of the first material and comprising pass-through openings sized so that formed components of the bodily fluid do not enter the bodily fluid pass-through region;

wherein the first capture region defines a first filter region of the separation material having an anti-hemolytic coating and pore spacing sized to constrain formed blood components therein;

wherein the bodily fluid pass-through region defines a second filter region of the separation material having pore spacing smaller than pore spacing of the first filter region with pores sized so that formed components do not enter the second filter region and configured to have an amount of anti-hemolytic coating less than that of the first region.

11. The separation material of claim 10 the separation material comprises at least two separate separation materials.

12. The separation material of claim 10 further comprising at least another region of the separation material between the first region and the second region.

13. The separation material of claim 10 where the first region is in fluid communication with the second region.

14. The separation material of claim 10 where the first region is spaced apart from the second region.

15. A bodily fluid separation material comprising:

a first capture region formed of a first material and having an anti-hemolytic surface coating not comprising the first material;

a second capture region formed of the first material and without the anti-hemolytic surface coating not comprising the first material; and

a bodily fluid pass-through region formed of the first material and comprising pass-through openings sized so that formed components of the bodily fluid do not enter the bodily fluid pass-through region;

wherein the first capture region, second capture region, and the bodily fluid pass-through region comprise a percolating network.

Assignments (6)
CHANGE OF NAME Recorded Apr 3, 2020
From: THERANOS IP COMPANY, LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 052313/0011 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2018
From: THERANOS, INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 045075/0310 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2017
From: THERANOS INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 044838/0909 →
SECURITY INTEREST Recorded Dec 12, 2017
From: THERANOS IP COMPANY, LLC
To: FORTRESS CREDIT CORP.
Reel/Frame 044839/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2017
From: SLOAN, DEBORAH; ANEKAL, SAMARTHA
To: THERANOS, INC.
Reel/Frame 044120/0165 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2017
From: SLOAN, DEBORAH; ANEKAL, SAMARTHA
To: THERANOS, INC.
Reel/Frame 043684/0667 →
Continuity (3)
Continuation 14214772 · Mar 15, 2014
Provisional Application 61799221 · Mar 15, 2013
Related Publication 20180104656A1 · Apr 19, 2018